녹아웃(KO) 마우스 | Cyagen Korea

Genetically engineered animals remain essential for gaining proper understanding of human disease mechanisms and play an important role in a variety of research areas.

For your reference, we now briefly summarize several recent publications from researchers using custom genetically modified models for a broad range of human disease studies, including neurological disorders, inflammatory disorders, cardiovascular disease, oncology, immunology, and kidney disease.

Models

Research Applications

Title

Journal

Knockin mice (TurboKnockout® based)

Neurology

Oxytocin-dependent reopening of a social reward learning critical period with MDMA

Nature, 2019

Knockin mice (ESC based)

Cardiovasology

Using Gjd3-CreEGFP mice to examine atrioventricular node morphology and composition

Scientific Reports, 2019.

Knockout Mice

Inflammatory disorders

VSIG4 mediates transcriptional inhibition of Nlrp3 and Il-1β in macrophages.

Science Advances, 2019

Neuropathology

AQP4ex is crucial for the anchoring of AQP4 at the astrocyte end-feet and for neuromyelitis optica antibody binding

Acta Neuropathologica Communications, 2019.

Cardiovascular disease

Inhibition of S-Adenosyl homocysteine Hydrolase Induces Endothelial Dysfunction via Epigenetic Regulation of p66shc-Mediated Oxidative Stress Pathway

Circulation, 2019.

Oncology

Heterozygous knockout insulin-like growth factor-1 receptor (IGF-1R) regulates mitochondrial functions and prevents colitis and colorectal cancer

Free Radical Biology and Medicine, 2019.

Conditional Knockout Mice

Osteoarthritis

Hematopoietic PBX-interacting protein mediates cartilage degeneration during the pathogenesis of osteoarthritis.

Nature Communications, 2019.

Cardiovascular disease

Thyrotropin aggravates atherosclerosis by promoting macrophage inflammation in plaques.

Journal of Experimental Medicine, 2019.

Immunology

Specific Decrease in B-Cell-Derived Extracellular Vesicles Enhances Post-Chemotherapeutic CD8+ T Cell Responses

Immunity, 2019.

Point Mutation Mice

Pancreatic disease

Heterozygous Spink1 c.194+2T>C mutant mice spontaneously develop chronic pancreatitis.

Gut, 2019.

Point Mutation Mice (Rosa26)

Infertility

A pannexin 1 channelopathy causes human oocyte death

Science Translational Medicine, 2019.

Rosa26 Conditional knockout Mice

Kidney disease

Tubular NOX4 expression decreases in chronic kidney disease but does not modify fibrosis evolution

Redox Biology, 2019.

Transgenic Mice

Cancer immunotherapy

Intratumoral Tcf1+PD-1+CD8+ T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy.

Immunity, 2019.

Immunology

Uniquely human CHRFAM7A gene increases the hematopoietic stem cell reservoir in mice and amplifies their inflammatory response

PNAS (Proceedings of the National Academy of Sciences of the United States of America), 2019.

Conditional Transgenic Mice

Colorectal Cancer (CRC)

CXCL12/CXCR4 promotes inflammation-driven colorectal cancer progression through activation of RhoA signaling by sponging miR-133a-3p

Journal of Experimental & Clinical Cancer Research, 2019.

Humanized Mice (Conditional knockin)

Oncology

An orally active galectin-3 antagonist inhibits lung adenocarcinoma growth and augments response to PD-L1 blockade

Cancer Research, 2019.

 

Visit our Citations page for a comprehensive, searchable listing of publications using custom animal models from Cyagen.

Did we miss you? Please contact us if you have published your studies using custom animal models provided by Cyagen that are not yet included in our citation resources.

If you need more information regarding our technologies and how Cyagen can help you further your research, please feel free to contact us with your gene target(s) and our custom model generation experts will be in touch with you.

2006 년에 설립된 Cyagen은 데이터, 알고리즘, 모델로 신약 개발을 가속화하는 혁신적인 CRO 기업으로, 동물 모델 맞춤화부터 유전자, 세포 치료 업무에 이르기까지 고객의 요구를 전방위적으로 충족합니다.
카톡 채널 팔로우 클릭
최신 동향을 파악
제품 업무 상담
전화:
86 20-31601779
이메일:
웹 사이트:
  • Contact Us

    영업일 기준 1-2일 내에 답변해 드리겠습니다.

    *

    The username is required

    *

    The user's email is required

    Please enter a valid email address.

    *

    The content is required

    *